Return to site

A New Approach to Revolutionize Clinical Trials

Helping with GBM funding: Sujuan Ba of the National Foundation for Cancer Research

It may be the biggest thing in medicine in a long time. It's not a new drug, or therapy or discovery. Instead it's a new way of doing clinical trials which could have a dramatic effect, particularly on those diseases that get less attention.

Initially it is aimed at the deadliest brain cancer, glioblastoma multiforme, known as GBM. From diagnosis, it can kill in about six months.

Traditionally clinical trials test one drug or a therapy on a lot of patients, sometimes thousands, against a control group that is treated with a placebo, or not treated at all. Trials drag on for years.